U.S. orthopedic soft tissue repair hit $2.3B in 2024, projected near $3.4B by 2031, driven by outpatient arthroscopy ...
Multiple sclerosis (MS) is a chronic neurological disease characterized by nerve damage and consequent impairments in vision, ...
Marks a world-first as Regentis uses MOCART, a quantitative standard to measure regeneration of cartilage in a clinical ...
BURTON, MI, UNITED STATES, January 9, 2026 /EINPresswire.com/ -- Javelin Sciences, a CLIA-certified biotechnology ...
CHICAGO, IL - January 08, 2026 - PRESSADVANTAGE - Universal Wellness Roscoe Village provides access to advanced ...
Peptides have emerged as critical tools in the investigation of physiological homeostasis, specifically in how biological systems manage energy substrates and recover from physical trauma. By ...
Galentine’s Day is a time for celebrating the fabulous ladies in your life, and there’s no better way to show you care than ...
Researchers at The University of Texas MD Anderson Cancer Center have discovered that targeting a specific immune process ...
Marks a world-first as Regentis uses MOCART, a quantitative standard to measure regeneration of cartilage in a clinical trial, as a predefined endpointNew peer-reviewed data published in the scientifi ...
News-Medical.Net on MSN
Stimulating immune cells could offer new treatment for nerve injury pain
Researchers at The University of Texas MD Anderson Cancer Center have discovered that targeting a specific immune process ...
TipRanks on MSN
Regentis Biomaterials publishes Phase II data showing long-term durability of GelrinC cartilage repair
Regentis Biomaterials Ltd ( ($RGNT) ) has shared an announcement. On January 6, 2025, Regentis Biomaterials announced peer-reviewed publication of ...
The utilization of biodegradable biomaterials as a therapeutic modality for musculoskeletal tissue regeneration has emerged as a promising avenue for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results